Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21721 AL 21735

Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases

Chen X, Ghribi O, Geiger JD.

J Alzheimers Dis. 2010;20 Suppl 1(Suppl 1):S127-41. doi: 10.3233/JAD-2010-1376.

Alzheimer's disease, Parkinson's disease and essential tremor: three common degenerative diseases with shared mechanisms?

Louis ED, Benito-León J.

Eur J Neurol. 2010 Jun 1;17(6):765-6. doi: 10.1111/j.1468-1331.2010.02976.x. Epub 2010 Feb 26.

[Sleep disturbances in Alzheimer's disease and other dementias]

Vecchierini MF.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):15-23. doi: 10.1684/pnv.2010.0203.

Detection of imminent collisions by drivers with Alzheimer's disease and Parkinson's disease: a preliminary study

Vaux LM, Ni R, Rizzo M, Uc EY, Andersen GJ.

Accid Anal Prev. 2010 May;42(3):852-8. doi: 10.1016/j.aap.2009.07.009.

Mitochondria dysfunction and neurodegenerative disorders: cause or consequence

Morais VA, De Strooper B.

J Alzheimers Dis. 2010;20 Suppl 2:S255-63. doi: 10.3233/JAD-2010-100345.

Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment

Chase TN.

Neurotox Res. 2011 Feb;19(2):266-78. doi: 10.1007/s12640-010-9196-9. Epub 2010 May 15.

New therapeutic strategy for Parkinson's and Alzheimer's disease

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. doi: 10.2174/092986710791859324.

Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction

Badoer E.

Int J Biochem Cell Biol. 2010 Oct;42(10):1580-5. doi: 10.1016/j.biocel.2010.07.005. Epub 2010 Jul 16.

Brain iron metabolism and its perturbation in neurological diseases

Crichton RR, Dexter DT, Ward RJ.

J Neural Transm (Vienna). 2011 Mar;118(3):301-14. doi: 10.1007/s00702-010-0470-z. Epub 2010 Sep 1.

Astrocytes in Alzheimer's disease

Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ.

Neurotherapeutics. 2010 Oct;7(4):399-412. doi: 10.1016/j.nurt.2010.05.017.

T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia

Haris M, Singh A, Cai K, Davatzikos C, Trojanowski JQ, Melhem ER, Clark CM, Borthakur A.

J Neurol. 2011 Mar;258(3):380-5. doi: 10.1007/s00415-010-5762-6. Epub 2010 Oct 7.

Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study

Katsarou Z, Bostantjopoulou S, Zikouli A, Kazazi E, Kafantari A, Tsipropoulou V, Kourtesi G, Peitsidou E.

Int J Neurosci. 2010 Nov;120(11):724-30. doi: 10.3109/00207454.2010.518779.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias